Intermountain Health Stresses the Importance of Early Breast Cancer Detection

Breast cancer affects 1 in 8 women in their lifetime, making it one of the most pressing health concerns for women. However, thanks to improved awareness, early detection, and advancements in treatment, survival rates have significantly improved over the years. According to the American Cancer Society (ACS), the 5-year survival rate for breast cancer is now 90-percent, and when detected early, that rate can be as high as 99-percent.

“Breast cancer is still the most prevalent cancer among women, and early detection is crucial for increasing the chances of survival,” stated Dr. Jeffrey Gilroy, a radiation oncologist with Intermountain Health St. James Hospital - Cancer Centers of Montana.

“A key tool for early detection is the mammogram, which uses images of the breast to find tumors and abnormalities before they can be physically detected, usually when treatment is more effective and less invasive.”

Starting at age 40, all women should get a yearly mammogram. For women at a higher risk of breast cancer because of family history or other factors, screening may start earlier and be more frequent. Women should talk to their doctor about whether they should start getting mammograms sooner and if they would benefit from additional screening such as an MRI or whole breast ultrasound.

LATEST RESEARCH: Breast cancer research has made remarkable strides in recent years, providing new hope for patients and their families. One of the most significant advancements is the development of targeted therapies.

An area of research is in immunotherapy, which leverages the body’s immune system to fight cancer. Immunotherapy has shown promising results in treating other types of cancer, and researchers are exploring its potential for breast cancer patients, particularly those with triple-negative breast cancer, which has fewer treatment options.

Advances in genetic testing are also helping to personalize breast cancer treatment. Genetic tests can now identify specific mutations, such as BRCA1 and BRCA2, which increase the risk of developing breast cancer. Women with these mutations can take preventative measures, such as enhanced screening, medication, or preventive surgery, to reduce their risk.

ANNUAL SCREENING MAMMOGRAMS: In addition to treatment advances, there is ongoing research focused on improving screening technology. 3D mammography, also known as tomosynthesis, is becoming more widely available. This newer imaging technology creates a more detailed, three- dimensional picture of the breast, improving accuracy and reducing the chances of false positives or missed diagnoses.

“Even with treatment progress, mammograms for early detection are still crucial in battling breast cancer,” said Dr. Justin Clark, MD, a breast imaging specialist at the St. James Imaging Center. “Consistent screening ensures cancer is detected at its most treatable, early stages. Women who miss or postpone their yearly screenings increase their chances of receiving a diagnosis at a more advanced stage, when the disease may be more severe and challenging to manage.”

To ensure you stay up to date on all your cancer screenings be sure to visit your primary care provider for your annual clinical exam and contact them immediately if you experience any abnormal changes.

Learn more at sjh-mt.org/mammography.